Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Current Oncology (Toronto, Ont.)|June 25, 2026
Real-World Survival Outcomes Following Chemoradiotherapy with or Without Durvalumab in PD-L1-Defined Subgroups of Stage III Unresectable NSCLCJanne Selke, Yvonne Dzierma, Katrin Manda, et al.Clinical and Experimental Immunology|January 12, 2022
Deciphering the Plasmodium falciparum malaria-specific CD4+ T-cell response: ex vivo detection of high frequencies of PD-1+TIGIT+ EXP1-specific CD4+ T cells using a novel HLA-DR11-restricted MHC class II tetramerSophia Schulte, Janna Heide, Christin Ackermann, et al.Frontiers in Immunology|February 11, 2020
Detection of EXP1-Specific CD4+ T Cell Responses Directed Against a Broad Range of Epitopes Including Two Promiscuous MHC Class II Binders During Acute Plasmodium falciparum MalariaJanna Heide, Nils H Wildner, Christin Ackermann, et al.Frontiers in Immunology|May 9, 2022
Inversed Ratio of CD39/CD73 Expression on γδ T Cells in HIV Versus Healthy Controls Correlates With Immune Activation and Disease ProgressionKatharina Kolbe, Melanie Wittner, Philip Hartjen, et al.Hepatology Communications|July 31, 2024
B cells expressing mutated IGHV1-69-encoded antigen receptors related to virus neutralization show lymphoma-like transcriptomes in patients with chronic HCV infectionChristoph Schultheiß, Edith Willscher, Lisa Paschold, et al.Frontiers in Immunology|October 25, 2023
Immunosuppressive M2 TAMs represent a promising target population to enhance phagocytosis of ovarian cancer cells in vitroFranziska Brauneck, Leticia Oliveira-Ferrer, Jana Muschhammer, et al.Scientific Reports|July 25, 2019
HCV-specific CD4+ T cells of patients with acute and chronic HCV infection display high expression of TIGIT and other co-inhibitory moleculesChristin Ackermann, Maike Smits, Robin Woost, et al.Journal for Immunotherapy of Cancer|December 22, 2022
TIGIT blockade repolarizes AML-associated TIGIT+ M2 macrophages to an M1 phenotype and increases CD47-mediated phagocytosisFranziska Brauneck, Brit Fischer, Marius Witt, et al.Journal of Leukocyte Biology|February 15, 2017
Down-regulation of CD73 on B cells of patients with viremic HIV correlates with B cell activation and disease progressionEun-Seong Kim, Christin Ackermann, Ilona Tóth, et al.The Journal of Infectious Diseases|September 25, 2018
Detection of a Broad Range of Low-Level Major Histocompatibility Complex Class II-Restricted, Hepatitis Delta Virus (HDV)-Specific T-Cell Responses Regardless of Clinical StatusJohanna Landahl, Jan Hendrik Bockmann, Christoph Scheurich, et al.Pageof 2